These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 26313898

  • 1. Obesity medications: what does the future look like?
    Butsch WS.
    Curr Opin Endocrinol Diabetes Obes; 2015 Oct; 22(5):360-6. PubMed ID: 26313898
    [Abstract] [Full Text] [Related]

  • 2. New antiobesity agents: lorcaserin (Belviq) and phentermine/topiramate ER (Qsymia).
    Shyh G, Cheng-Lai A.
    Cardiol Rev; 2014 Oct; 22(1):43-50. PubMed ID: 24304809
    [Abstract] [Full Text] [Related]

  • 3. Comparison table: some FDA-approved drugs for weight management.
    Med Lett Drugs Ther; 2018 Jun 04; 60(1548):e98-e100. PubMed ID: 29913464
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacotherapy of Obesity: Clinical Trials to Clinical Practice.
    Gadde KM, Pritham Raj Y.
    Curr Diab Rep; 2017 May 04; 17(5):34. PubMed ID: 28378293
    [Abstract] [Full Text] [Related]

  • 5. Drug treatment of obesity: current status and future prospects.
    Kakkar AK, Dahiya N.
    Eur J Intern Med; 2015 Mar 04; 26(2):89-94. PubMed ID: 25634851
    [Abstract] [Full Text] [Related]

  • 6. Drug safety evaluation of naltrexone/bupropion for the treatment of obesity.
    Verpeut JL, Bello NT.
    Expert Opin Drug Saf; 2014 Jun 04; 13(6):831-41. PubMed ID: 24766397
    [Abstract] [Full Text] [Related]

  • 7. Overview of new antiobesity drugs.
    Hainer V.
    Expert Opin Pharmacother; 2014 Oct 04; 15(14):1975-8. PubMed ID: 25100293
    [Abstract] [Full Text] [Related]

  • 8. New molecular targets in the pathophysiology of obesity and available treatment options under investigation.
    Valsamakis G, Lois K, Kumar S, Mastorakos G.
    Clin Obes; 2014 Aug 04; 4(4):209-19. PubMed ID: 25826792
    [Abstract] [Full Text] [Related]

  • 9. [The pharmacotherapy of obesity].
    Budai KA, Mirzahosseini A, Noszál Béla, Tóth G.
    Acta Pharm Hung; 2015 Aug 04; 85(1):3-17. PubMed ID: 26137782
    [Abstract] [Full Text] [Related]

  • 10. Evolution of pharmacological obesity treatments: focus on adverse side-effect profiles.
    Krentz AJ, Fujioka K, Hompesch M.
    Diabetes Obes Metab; 2016 Jun 04; 18(6):558-70. PubMed ID: 26936802
    [Abstract] [Full Text] [Related]

  • 11. Pharmacotherapy for Obesity.
    Saunders KH, Shukla AP, Igel LI, Kumar RB, Aronne LJ.
    Endocrinol Metab Clin North Am; 2016 Sep 04; 45(3):521-38. PubMed ID: 27519128
    [Abstract] [Full Text] [Related]

  • 12. Epidemiology of Obesity and Pharmacologic Treatment Options.
    Shettar V, Patel S, Kidambi S.
    Nutr Clin Pract; 2017 Aug 04; 32(4):441-462. PubMed ID: 28632997
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. New medications for obesity management: changing the landscape of obesity treatment.
    Boulghassoul-Pietrzykowska N, Franceschelli J, Still C.
    Curr Opin Endocrinol Diabetes Obes; 2013 Oct 04; 20(5):407-11. PubMed ID: 23974768
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Past and present of antiobesity agents: focus on monoamine modulators.
    Khorassani FE, Misher A, Garris S.
    Am J Health Syst Pharm; 2015 May 01; 72(9):697-706. PubMed ID: 25873617
    [Abstract] [Full Text] [Related]

  • 19. Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.
    Bays H.
    Expert Rev Cardiovasc Ther; 2010 Dec 01; 8(12):1777-801. PubMed ID: 20707765
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological therapies for obesity.
    Kaplan LM.
    Gastroenterol Clin North Am; 2005 Mar 01; 34(1):91-104. PubMed ID: 15823441
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.